Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001) - Shang, Xiaobin; Zhao, Gang; Liang, Fei; Zhang, Chen; Zhang, Weihong; Liu, Liang; Li, Runmei; Duan, Xiaofeng; Ma, Zhao; Yue, Jie; Chen, Chuangui; Meng, Bin; et al. (Annals of translational medicine, 2022)
Keywords: Study Protocol; pembrolizumab; locally advanced; neoadjuvant therapy; Esophageal squamous cell carcinoma (ESCC)